Autoimmune Disease Treatment Market Set to Surge, Predicts Credence Research: USD 208.61 Bn Valuation Expected by 2030

Advertisements
Autoimmune Diseases Treatment Market
Autoimmune Diseases Treatment Market By Product Type (B Cell Inhibitors, T Cell Inhibitors, Tumor Necrosis Factor ,Inhibitors, Interleukin Inhibitors ,Immunosuppressants, Beta Interferons, Insulin, Others) By Application (Graves Disease ,Rheumatoid Arthritis , Hashimotos Thyroiditis, Vitiligo, Type 1 Diabetes, Pernicious Anemia ,Others) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Credence Research, a leading global market research and advisory firm, has announced its analysis of the global autoimmune disease therapeutics market. The market, valued at USD 159.6 billion in 2022, is projected to reach USD 208.61 billion by 2030, registering a CAGR of 3.90% from 2018 to 2030. This significant growth is primarily driven by the increase in the incidence of autoimmune diseases, surge in adoption of autoimmune disease therapeutics, and growth in R&D activities to develop effective therapeutics.

Autoimmune diseases, where the immune system destroys its own body tissue, include more than 80 different types, with lupus, multiple sclerosis, IBS, type 1 diabetes, rheumatoid arthritis, and psoriasis being the most common.

The market includes various types of drugs such as anti-inflammatory, NSAIDs, interferons, immune suppressants, corticosteroids, and others, approved for the treatment of autoimmune disease. The study forecasts that the anti-inflammatory drug class will continue to hold the largest market share due to the rising demand and launch of newer drugs, as well as favorable reimbursement policies in certain countries.

Segmentation of the market includes drug class, indication, sales channel, and region. Rheumatic disease is the dominant indication, holding nearly half of the autoimmune disease therapeutics market share in 2017. This dominance is attributed to the strong presence of pipeline drugs and the increasing prevalence of diseases such as arthritis, fibromyalgia, systemic lupus erythematosus, gout, and others.

The Asia-Pacific region holds promising growth opportunities due to a large population base, increase in purchasing power, and surge in the prevalence of autoimmune diseases. An aging population, early disease detection, and rising healthcare expenditure further fuel market growth in this region.

Key players in the market include Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, Pfizer Inc., and UCB S.A.

This comprehensive analysis of the market provides stakeholders with insights into current trends and future estimations, enabling them to capitalize on the prevailing market opportunities from 2018 to 2030.

Table of content:

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Research Methodology

1.3.1. Phase I – Secondary Research

1.3.2. Phase II – Data Modelling

1.3.2.1. Company Share Analysis Model

1.3.2.2. Revenue Based Modelling

1.3.3. Phase III – Primary Research

1.3.4. Research Limitations

1.3.5. Assumptions

1.4. Market Introduction

1.5. Market Research Scope

 

2. Executive Summary

2.1. Market Snapshot: Global Autoimmune Diseases Treatment Market

2.2. Global Autoimmune Diseases Treatment Market, By Product Type

2.3. Global Autoimmune Diseases Treatment Market, By Application

2.4. Global Autoimmune Diseases Treatment Market, By Distribution Channel

2.5. Global Autoimmune Diseases Treatment Market, By Disease

2.6. Global Autoimmune Diseases Treatment Market, By Mechanism of Action

2.7. Global Autoimmune Diseases Treatment Market, By Diagnostic

2.8. Global Autoimmune Diseases Treatment Market, By Treatment

2.9. Global Autoimmune Diseases Treatment Market, By Product

2.10. Global Autoimmune Diseases Treatment Market, By Region

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Autoimmune Diseases Treatment Market Value, 2017-2030, (US$ Bn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Market Drivers

3.2.1.1. Driver 1

3.2.1.2. Driver 2

3.2.1.3. Driver 3

3.2.2. Market Restraints

3.2.2.1. Restraint 1

3.2.2.2. Restraint 2

3.2.3. Market Opportunities

3.2.3.1. Opportunity 1

3.2.3.2. Opportunity 2

3.2.4. Major Industry Challenges

3.2.4.1. Challenge 1

3.2.4.2. Challenge 2

3.3. Growth and Development and Extracellular Vesicles Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Product Type

3.5.2. Application

3.5.3. Distribution Channel

3.5.4. Disease

3.5.5. Product

3.5.6. Diagnostic

3.5.7. Treatment

3.5.8. Product

3.5.9. Geography

 

4. Premium Insights

4.1. STAR (Situation, Task, Action, Results) Analysis

4.2. Porter’s Five Forces Analysis

4.2.1. Threat of New Entrants

4.2.2. Bargaining Power of Buyers/Consumers

4.2.3. Bargaining Power of Suppliers

4.2.4. Threat of Substitute Types

4.2.5. Intensity of Competitive Rivalry

4.3. Key Market Trends

4.3.1. Demand Side Trends

4.3.2. Supply Side Trends

4.4. Value Chain Analysis

4.5. Product Type Analysis

4.6. Analysis and Recommendations

4.7. Marketing Strategy Analysis

4.7.1. Direct Marketing

4.7.2. Indirect Marketing

4.7.3. Marketing Channel Development Trend

 

5. Market Positioning of Key Players, 2022

………..

 

6. Economic Impact Analysis

6.1. Recession Impact

6.1.1. North America

6.1.2. Europe

6.1.3. Asia Pacific

6.1.4. Latin America

6.1.5. Middle East and Africa

6.2. Ukraine-Russia War Impact

6.2.1. North America

6.2.2. Europe

6.2.3. Asia Pacific

6.2.4. Latin America

6.2.5. Middle East and Africa

6.3. COVID-19 Impact Analysis

6.3.1. North America

6.3.2. Europe

6.3.3. Asia Pacific

6.3.4. Latin America

6.3.5. Middle East and Africa

 

7. Global Autoimmune Diseases Treatment Market, By Product Type

………….

 

8. Global Autoimmune Diseases Treatment Market, By Application

…………

 

9. Global Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030 (US$ Bn)

…………

 

10. Global Autoimmune Diseases Treatment Market, by Disease, 2017-2030 (US$ Bn)

………..

 

11. Global Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030 (US$ Bn)

…………

 

12. Global Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030 (US$ Bn)

………..

 

13. Global Autoimmune Diseases Treatment Market, by Treatment, 2017-2030 (US$ Bn)

……….

 

14. Global Autoimmune Diseases Treatment Market, by Product, 2017-2030 (US$ Bn)

14.1. Global Autoimmune Diseases Treatment Market Overview, by Product

14.1.1. Global Autoimmune Diseases Treatment Market, By Product, 2022 vs 2030 (in%)

14.2. Diagnostic Equipment

14.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

14.3. Drugs

14.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

14.4. Therapeutic & Monitoring Equipment

14.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

 

15. Global Autoimmune Diseases Treatment Market, By Region

………..

 

16. North America Autoimmune Diseases Treatment Market Analysis

…………….

 

17. Europe Autoimmune Diseases Treatment Market Analysis

………….

 

18. Asia Pacific Autoimmune Diseases Treatment Market Analysis

…………

 

19. Latin America Autoimmune Diseases Treatment Market Analysis

………..

 

20. Middle East and Africa Autoimmune Diseases Treatment Market Analysis

…………

 

21. Company Profiles

21.1. Abbvie

21.1.1. Company Overview

21.1.2. Diagnostic/Services Portfolio

21.1.3. Geographical Presence

21.1.4. Financial Summary

21.1.4.1. Market Revenue and Net Profit (2019-2022)

21.1.4.2. Business Segment Revenue Analysis

21.1.4.3. Geographical Revenue Analysis

21.2. Amgen Inc.

21.3. Johnson & Johnson

21.4. Eli Lilly and Company

21.5. Pfizer Inc.

21.6. F. Hoffmann-La Roche AG

21.7. Astrazeneca Plc

21.8. Bristol-Myers Squibb Co.

21.9. Lupin Limited

21.10. GlaxoSmithKline Plc

……………toc continued

Browse Full Report with Table List and Figures- https://www.credenceresearch.com/report/autoimmune-diseases-treatment-market

Related Reports:

E-Paper Display Market 

Electric Pallet Jack And Stacker Market

Door Closer and Exit Devices Market

About Us

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Media Contact
Company Name: Credence Research
Contact Person: Gunakesh Parmar
Email: Send Email
Phone: +91 8085895002
City: Gwalior
State: MP
Country: India
Website: https://www.credenceresearch.com/report/autoimmune-diseases-treatment-market

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.

Advertisements

Smart public opinion research for everyone.

Generated by Feedzy
%d bloggers like this: